Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.11 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enriched outside the brain (hepatocytes) | 0.10 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | 36 Parkinson's trials, 2 stopped | 0.96 |
| literature PubMed | 142 Parkinson's papers of 85,580 | 0.35 |
| pathways Reactome | 1 pathway; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 2389
Sealed predictions
- CRP in dopamine neurons, braak+0.25 (p 0.514) → +0.05 (p 0.891)receipt 2397
Swarm cases
receipt 2397: CRP in dopamine neurons, braak
- power
- full sample +0.13 (p 0.603, n 18), 95% CI -0.36 to +0.56. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.05 (p 0.847, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.00 (p 0.990, n 18). could be the mix.
- skeptic
- leave-one-out range +0.05 to +0.30, sign flips 0; without severely affected donors +0.13 (p 0.603, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CRP in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts